APOLLO is a national observational study. The purpose of this study is to test kidney donors and
kidney transplant recipients for variants (or forms) of the apolipoprotein L1 gene (called APOL1)
to determine whether they impact outcomes. APOLLO will follow individuals who receive a kidney
from an eligible (living or deceased) kidney donor. In addition, APOLLO will follow individuals
who donate a kidney to assess the impact of the APOL1 gene. This study is being done to improve
outcomes after kidney donation and kidney transplantation.
APOLLO is coordinated by the Wake Forest School of Medicine and has 13 Network Hubs that will work with all of the transplant programs in the United States, including Puerto Rico.
More information »
Potential Participants and Community »